Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Change in Receivables (2017 - 2025)

Historic Change in Receivables for Neuronetics (STIM) over the last 9 years, with Q3 2025 value amounting to -$3.9 million.

  • Neuronetics' Change in Receivables fell 71317.46% to -$3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.5 million, marking a year-over-year decrease of 13150.89%. This contributed to the annual value of $3.7 million for FY2024, which is 5779.64% down from last year.
  • As of Q3 2025, Neuronetics' Change in Receivables stood at -$3.9 million, which was down 71317.46% from -$148000.0 recorded in Q2 2025.
  • Neuronetics' 5-year Change in Receivables high stood at $3.5 million for Q2 2022, and its period low was -$3.9 million during Q3 2025.
  • Moreover, its 5-year median value for Change in Receivables was $898000.0 (2023), whereas its average is $1.1 million.
  • Its Change in Receivables has fluctuated over the past 5 years, first surged by 36980.2% in 2022, then plummeted by 71317.46% in 2025.
  • Neuronetics' Change in Receivables (Quarter) stood at $720000.0 in 2021, then skyrocketed by 187.92% to $2.1 million in 2022, then crashed by 56.68% to $898000.0 in 2023, then tumbled by 111.92% to -$107000.0 in 2024, then tumbled by 3510.28% to -$3.9 million in 2025.
  • Its last three reported values are -$3.9 million in Q3 2025, -$148000.0 for Q2 2025, and $2.6 million during Q1 2025.